Company news
Sera Prognostics, Inc. news in 2022
Sera Prognostics, Inc.'s news releases, calls and decks from 2022, newest first.
SERA Prognostics announces publication of data predicting clinical utility and cost effectiveness of the PreTRM® test-and-treat strategy across diverse populations
November 14, 2022
SERA Prognostics reports third quarter 2022 financial results
November 8, 2022
Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9
October 26, 2022
SERA Prognostics reports second quarter 2022 financial results
August 9, 2022
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2022 Financial Results on August 10
July 27, 2022
SERA Prognostics announces publication of data demonstrating improved performance of its PreTRM® test with more precise gestational age
May 18, 2022
SERA Prognostics presents data demonstrating the health and economic benefit of PreTRM® testing at ispor annual meeting
May 17, 2022
SERA Prognostics reports first quarter 2022 financial results
May 9, 2022
SERA Prognostics and Newborn Foundation partner to reduce risks associated with preterm birth and improve health equity through the "Every Mother, Every Baby" Project
May 4, 2022
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2022 Financial Results on May 10
May 1, 2022
SERA Prognostics announces the appointment of Dr. Jane F. Barlow to the SERA Prognostics board
April 11, 2022
SERA Prognostics reports fourth quarter 2021 financial results
March 28, 2022
Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting
March 17, 2022
Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2021 Financial Results on March 29
March 17, 2022
SERA Prognostics presentation rescheduled for Citi 2022 Healthcare Conference
February 16, 2022
SERA Prognostics announces new agreement with MultiPlan, expanding patient access to the PreTRM® test
January 31, 2022